国货高端护肤第一股诞生！林清轩成功登陆港交所，以细胞级抗皱科技引领行业革新

Core Viewpoint - Lin Qingxuan officially listed on the Hong Kong Stock Exchange on December 30, becoming the first high-end domestic skincare stock in the Hong Kong market, showcasing the strength and confidence of domestic brands on the international stage [1] Group 1: Company Overview - Lin Qingxuan focuses on anti-wrinkle and firming skincare products, providing high-end solutions with natural camellia ingredients [1] - The company has established a strong professional recognition in the "oil-based skincare" sector, ranking first among domestic high-end skincare brands and being the only domestic representative among the top 15 high-end skincare brands in China [3] - The brand has achieved over 50 million sales of its camellia oil facial essence, maintaining the top position in the market for 11 consecutive years [3] Group 2: Product Development - The fifth generation of the camellia anti-wrinkle essence oil has been launched, featuring comprehensive iterations in efficacy verification, core ingredient ratios, and packaging [5] - The company has expanded its product matrix with several recognized products, including black gold cream 2.0 and high SPF sunscreen [6] - Lin Qingxuan controls the entire value chain from seedling cultivation to sales, ensuring product quality and stable supply [6] Group 3: Research and Innovation - The company has over 600 formula achievements and 87 patents, with 46 being invention patents, focusing on key areas like camellia extraction and anti-wrinkle technology [7] - A joint research laboratory with Shanghai Jiao Tong University will be established to explore anti-wrinkle mechanisms at the cellular level, aiming to integrate natural plant activity with modern life sciences [7] Group 4: Financial Performance - From 2022 to 2024, the company's revenue grew from 690 million to 1.21 billion, with a compound annual growth rate of 32.3%, significantly above the industry average [9] - In the first half of 2025, revenue surged by 98.3% to 1.05 billion compared to the same period in 2024, with adjusted net profit increasing by 117.4% [9] - The company aims to leverage its listing as a new starting point to further develop core technologies and expand its product matrix [9]